When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
SURF - Why Surface Oncology Is Flying Higher After Hours Today
Surface Oncology Inc.
Regulatory approvals are big wins for biotech companies. It is no different for cancer drug specialist Surface Oncology (NASDAQ: SURF) , the shares of which were up nearly 13% in early after-hours trading Tuesday following an important nod from the U.S. Food and Drug Administration (FDA).
After market close, Surface Oncology announced that the regulator granted the company's SRF617 orphan drug designation for the treatment of pancreatic cancer.